Dear allWe are looking for a researcher to explore the druggability of RNA-protein interactions with small molecule compounds. The successful candidate will identify and characterize novel, disease-implicated RNA-protein interactions, establishing and conducting assays to target those interactions pharmacologically. This project is a collaboration between Cellzome-GSK and two leading research groups in the field of RNA-protein interaction: the group of Matthias Hentze (EMBL-Heidelberg) and the group of Marco Marcia (EMBL Grenoble). This project offers the opportunity to work in multi-disciplinary, international teams in Heidelberg-Germany (Cellzome and EMBL) and in Grenoble, France (EMBL) and to explore modern drug discovery approaches (GSK). The ideal candidate will possess a PhD-level background in RNA biochemistry and an outstanding scientific track record, proven by high impact publications in peer-reviewed international journals. Experience in genomics or proteomics will be of advantage. Applicants should send their CV summarizing qualifications and experience, including the names and addresses of two referees to:
Dr. Marco Marcia [email protected] Kind regards, -- _________________________________________ Dr. Marco MARCIA Group Leader EMBL Grenoble 71 Avenue des Martyrs, room 254 38042 Grenoble Cedex 09 France phone (lab): 0033-(0)47620-7634/7040 phone (office): 0033-(0)47620-7759 fax: 0033-(0)47620-7199 email: [email protected] web: https://embl.fr/research/unit/marcia/
Project ad druggability RNA-Protein interactions .pdf
Description: application/acrobat
